| | | Single nucleotide variant (missense variant) | not specified +7 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Recombinase activating gene 2 deficiency +1 more | |
| | | Single nucleotide variant (missense variant) | Recombinase activating gene 2 deficiency +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Recombinase activating gene 2 deficiency | |
| | | Single nucleotide variant (missense variant) | Combined immunodeficiency with skin granulomas +5 more | |
| | | Single nucleotide variant (missense variant) | Recombinase activating gene 2 deficiency +2 more | |
| | | Single nucleotide variant (missense variant) | Recombinase activating gene 2 deficiency | |
| | | Single nucleotide variant (missense variant) | Recombinase activating gene 2 deficiency | |
| | | Single nucleotide variant (missense variant) | Recombinase activating gene 2 deficiency | |
| | | Single nucleotide variant (missense variant) | Recombinase activating gene 2 deficiency | |
| | | Single nucleotide variant (missense variant) | Recombinase activating gene 2 deficiency +2 more | |
| | | Single nucleotide variant (missense variant) | Recombinase activating gene 2 deficiency +2 more | |
| | | Single nucleotide variant (missense variant) | Recombinase activating gene 2 deficiency | |
| | | Single nucleotide variant (missense variant) | Recombinase activating gene 2 deficiency | |
| | | Single nucleotide variant (missense variant) | Recombinase activating gene 2 deficiency | |
| | | Single nucleotide variant (missense variant) | Recombinase activating gene 2 deficiency +2 more | |
| | | Single nucleotide variant (missense variant) | Recombinase activating gene 2 deficiency +2 more | |
| | | Single nucleotide variant (missense variant) | Recombinase activating gene 2 deficiency | |
| | | Single nucleotide variant (missense variant) | Recombinase activating gene 2 deficiency | |
| | | Single nucleotide variant (missense variant) | Recombinase activating gene 2 deficiency | |
| | | Single nucleotide variant (missense variant) | Recombinase activating gene 2 deficiency +1 more | |
| | | Single nucleotide variant (missense variant) | not provided +3 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant) | not provided +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Recombinase activating gene 2 deficiency +2 more | |
| | | Single nucleotide variant (missense variant) | Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Recombinase activating gene 2 deficiency +2 more | |
| | | Single nucleotide variant (missense variant) | Recombinase activating gene 2 deficiency +2 more | |
| | | Single nucleotide variant (missense variant) | Immunodeficiency 104 +6 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Recombinase activating gene 2 deficiency | |
| | | Single nucleotide variant (missense variant) | Recombinase activating gene 2 deficiency +2 more | |
| | | Single nucleotide variant (missense variant) | Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-positive +4 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant) | Recombinase activating gene 2 deficiency | |
| | | Single nucleotide variant (missense variant) | RAG2-related disorder +5 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant) | Atypical severe combined immunodeficiency due to complete RAG1/2 deficiency +5 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant +1 more) | Recombinase activating gene 2 deficiency | |